Table 7.
Characteristics of individuals who had SARS-CoV-2 infection associated with higher costs of care in the following months
| Covariates | OR | 95% CI |
| Sex | ||
| Female | 1 | |
| Male | 0.67 | (0.63 to 0.71) |
| Age | ||
| <30 | 1 | |
| 31–50 | 2.17 | (2.01 to 2.34) |
| 51–70 | 3.71 | (3.44 to 4.00) |
| >71 | 4.75 | (4.32 to 5.23) |
| Charlson Index | ||
| 0 | 1 | |
| 1 | 2.09 | (1.86 to 2.36) |
| 2 | 2.96 | (2.60 to 3.39) |
| >3 | 4.00 | (3.42 to 4.78) |
| Had anti-SARS-CoV-2 vaccine | ||
| No | 1 | |
| Yes | 0.36 | (0.30 to 0.43) |
| Had symptomatic infection | ||
| No | 1 | |
| Yes | 1.32 | (1.23 to 1.41) |
| Had hospital admission for COVID-19 | ||
| No | 1 | |
| Yes | 1.66 | (1.50 to 1.83) |